Home › NDC Lookup › RxCUI directory › RxCUI 1801279

Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension — RxCUI 1801279

RxNorm drug concept · Semantic clinical drug
RxCUI 1801279 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 36 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1801279
Official nameSugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascholestyramine Sugar-Free 4 GM Powder for Oral Suspension
FDA products mapped21
Package NDCs mapped36
Reported Medicaid activity (SDUD)32,036 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Sugar-Free cholestyramine resin 4000 MG Powder f... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension RxCUI 1801279

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cholestyramine resin 2447
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prevalite 219397
    • Questran 202582
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cholestyramine resin Powder for Oral Suspension 1801266
    • Cholestyramine resin Oral Powder Product 1801265
    • Cholestyramine resin Oral Product 1156140
    • Cholestyramine resin Powder for Oral Suspension [Prevalite] 1801273
    • Cholestyramine resin Powder for Oral Suspension [Questran] 1801269
    • Prevalite Oral Powder Product 1801274
    • Prevalite Oral Product 1177645
    • Questran Oral Powder Product 1801270
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cholestyramine resin 4000 MG SCDC · 317329
  • Cholestyramine resin Powder for Oral Suspension SCDF · 1801266
  • Cholestyramine resin Oral Powder Product SCDG · 1801265
  • Cholestyramine resin Oral Product SCDG · 1156140

Brand-Name Concepts

📦 FDA Products & Package NDCs

21 products · 36 package NDCs
36 package NDCs map to RxCUI 1801279 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00245-0036-23 231 g in 1 CAN (0245-0036-23) Prevalite Upsher-Smith Laboratories, LLC 1996-02-01
00245-0036-42 42 PACKET in 1 CARTON (0245-0036-42) / 5.5 g in 1 PACKET (0... Prevalite Upsher-Smith Laboratories, LLC 1996-02-01
00245-0036-60 60 PACKET in 1 CARTON (0245-0036-60) / 5.5 g in 1 PACKET (0... Prevalite Upsher-Smith Laboratories, LLC 1996-02-01
24658-0270-95 60 POUCH in 1 CARTON (24658-270-95) / 5.7 g in 1 POUCH CHOLESTYRAMINE LIGHT PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS 2023-03-14
24658-0271-93 239.4 g in 1 JAR (24658-271-93) CHOLESTYRAMINE LIGHT PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS 2024-04-29
24658-0271-97 239.4 g in 1 CAN (24658-271-97) CHOLESTYRAMINE LIGHT PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS 2023-03-14
33342-0319-70 60 POUCH in 1 CARTON (33342-319-70) / 5.7 g in 1 POUCH (333... Cholestyramine Macleods Pharmaceuticals Limited 2024-11-21
33342-0319-72 42 POUCH in 1 CARTON (33342-319-72) / 5.7 g in 1 POUCH (333... Cholestyramine Macleods Pharmaceuticals Limited 2024-11-21
33342-0319-83 239.4 g in 1 JAR (33342-319-83) Cholestyramine Macleods Pharmaceuticals Limited 2024-11-21
42806-0269-98 5.7 g in 1 POUCH (42806-269-98) CHOLESTYRAMINE LIGHT EPIC PHARMA, LLC 2021-12-15
42806-0270-95 60 POUCH in 1 CARTON (42806-270-95) / 5.7 g in 1 POUCH (428... CHOLESTYRAMINE LIGHT EPIC PHARMA, LLC 2021-12-15
42806-0271-93 239.6 g in 1 JAR (42806-271-93) CHOLESTYRAMINE LIGHT EPIC PHARMA, LLC 2023-09-29
42806-0271-97 239.6 g in 1 CAN (42806-271-97) CHOLESTYRAMINE LIGHT EPIC PHARMA, LLC 2021-12-15
49884-0465-51 378 g in 1 BOTTLE (49884-465-51) Cholestyramine Par Health USA, LLC 2026-04-24
49884-0465-65 60 PACKET in 1 CARTON (49884-465-65) / 9 g in 1 PACKET (498... Cholestyramine Par Health USA, LLC 2005-09-15
49884-0465-66 378 g in 1 CAN (49884-465-66) Cholestyramine Par Health USA, LLC 2005-09-15
49884-0466-50 210 g in 1 BOTTLE (49884-466-50) Cholestyramine Par Health USA, LLC 2026-04-24
49884-0466-65 60 PACKET in 1 CARTON (49884-466-65) / 5 g in 1 PACKET (498... Cholestyramine Par Health USA, LLC 2005-09-15
49884-0466-67 210 g in 1 CAN (49884-466-67) Cholestyramine Par Health USA, LLC 2005-09-15
49884-0936-65 60 PACKET in 1 CARTON (49884-936-65) / 9 g in 1 PACKET (498... QUESTRAN Endo USA, Inc. 2005-09-15
49884-0936-66 378 g in 1 CAN (49884-936-66) QUESTRAN Endo USA, Inc. 2005-09-15
49884-0937-67 210 g in 1 CAN (49884-937-67) QUESTRAN Endo USA, Inc. 2003-07-24
51224-0009-10 201.6 g in 1 CAN (51224-009-10) Cholestyramine Light TAGI Pharma, Inc. 2020-11-12
62135-0008-56 378 g in 1 CAN (62135-008-56) Cholestyramine for Oral Suspension Chartwell RX, LLC 2023-01-03
62135-0937-54 239.4 g in 1 CAN (62135-937-54) Cholestyramine for Oral Suspension Chartwell RX, LLC 2023-01-03
63629-2162-01 210 g in 1 CAN (63629-2162-1) Cholestyramine Bryant Ranch Prepack 2005-09-15
63629-9466-01 60 POUCH in 1 CARTON (63629-9466-1) / 5.718 g in 1 POUCH Choleystyramine Light Bryant Ranch Prepack 2022-11-28
67877-0422-24 240.156 g in 1 JAR (67877-422-24) Choleystyramine Light Ascend Laboratories, LLC 2021-10-20
67877-0422-60 60 POUCH in 1 CARTON (67877-422-60) / 5.718 g in 1 POUCH (6... Choleystyramine Light Ascend Laboratories, LLC 2021-10-20
68094-0906-10 201.6 g in 1 CAN (68094-906-10) Cholestyramine Precision Dose, Inc. 2023-12-15
68094-0906-20 60 POUCH in 1 CARTON (68094-906-20) / 4.8 g in 1 POUCH Cholestyramine Precision Dose, Inc. 2023-12-15
68382-0529-42 231 g in 1 CONTAINER (68382-529-42) CHOLESTYRAMINE Zydus Pharmaceuticals (USA) Inc. 2017-06-08
68382-0529-60 60 POUCH in 1 CARTON (68382-529-60) / 5.5 g in 1 POUCH CHOLESTYRAMINE Zydus Pharmaceuticals (USA) Inc. 2017-06-08
70771-1070-01 231 g in 1 CONTAINER (70771-1070-1) CHOLESTYRAMINE Zydus Lifesciences Limited 2017-06-08
70771-1070-02 60 POUCH in 1 CARTON (70771-1070-2) / 5.5 g in 1 POUCH CHOLESTYRAMINE Zydus Lifesciences Limited 2017-06-08
72162-1505-02 210 g in 1 CAN (72162-1505-2) Cholestyramine Bryant Ranch Prepack 2024-03-15
Observed labelers: Par Health USA, LLC (6) · EPIC PHARMA, LLC (4) · Bryant Ranch Prepack (3) · Endo USA, Inc. (3) · Macleods Pharmaceuticals Limited (3) · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS (3) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.